| 000 | 01787 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514183831.0 | ||
| 264 | 0 | _c20041124 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0767-3981 | ||
| 024 | 7 |
_a10.1111/j.1472-8206.2003.00227.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTavares, Eva | |
| 245 | 0 | 0 |
_aDifferential sensitivities of pyrogenic chemokine fevers to CC chemokine receptor 5 antibodies. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _cApr 2004 |
||
| 300 |
_a163-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xadministration & dosage |
| 650 | 0 | 4 |
_aBody Temperature _xdrug effects |
| 650 | 0 | 4 | _aCCR5 Receptor Antagonists |
| 650 | 0 | 4 |
_aCerebrospinal Fluid _xchemistry |
| 650 | 0 | 4 | _aChemokine CCL4 |
| 650 | 0 | 4 |
_aChemokine CCL5 _xadministration & dosage |
| 650 | 0 | 4 |
_aChemokines, CC _xadministration & dosage |
| 650 | 0 | 4 |
_aFever _xchemically induced |
| 650 | 0 | 4 | _aHeating |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicroinjections _xmethods |
| 650 | 0 | 4 |
_aPreoptic Area _xanatomy & histology |
| 650 | 0 | 4 |
_aPyrogens _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, CCR5 _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
| 650 | 0 | 4 | _aStereotaxic Techniques |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMiñano, Francisco J | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 18 _gno. 2 _gp. 163-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1472-8206.2003.00227.x _zAvailable from publisher's website |
| 999 |
_c14781691 _d14781691 |
||